Cleared Traditional

K263150 - V10 Diagnostic Ultrasound System

Also marketed or referenced as:
cV10 Diagnostic Ultrasound System H10 Diagnostic Ultrasound System XV10 Diagnostic Ultrasound System XH10 Diagnostic Ultrasound System V10 ONE Diagnostic Ultrasound System cV10 ONE Diagnostic Ultrasound System H10 ONE Diagnostic Ultrasound System XV10 ONE Diagnostic Ultrasound System XH10 ONE Diagnostic Ultrasound System HERA Z10 Diagnostic Ultrasound System

K263150 is an FDA 510(k) clearance for V10 Diagnostic Ultrasound System, manufactured by Samsung Medison Co., Ltd.. The device is a Class 2 Radiology device with product code IYN cleared through the Traditional 510(k) pathway after a 30-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2026
Decision
30d
Days
Class 2
Risk

K263150 is an FDA 510(k) clearance for the V10 Diagnostic Ultrasound System. Classified as System, Imaging, Pulsed Doppler, Ultrasonic within the IYN classification (a category covering pulsed Doppler and ultrasound imaging systems), Class II - Special Controls.

Submitted by Samsung Medison Co., Ltd. (Hongcheon-Gun, KR). The FDA issued a Cleared decision on October 8, 2026 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1550 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K263150

510(k) Number K263150 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 08, 2026
Decision Date October 08, 2026
Days to Decision 30 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 107d · This submission: 30d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

IYN Device Classification - Class 2, Special Controls

Product Code IYN System, Imaging, Pulsed Doppler, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
Prithul Bom

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - IYN System, Imaging, Pulsed Doppler, Ultrasonic

All 1186
Devices cleared under the same product code (IYN) and FDA review panel - the closest regulatory comparables to K263150.
Diagnostic Ultrasound System (Nuewa A20W)
K261585 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Oct 2026
Diagnostic Ultrasound System (Resona I10W)
K261617 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Oct 2026
Voluson Expert 18
K261933 · GE Medical Systems Ultrasound and Primary care Diagnostics, LLC · Oct 2026
EPIQ Inspira Series Diagnostic Ultrasound System
K262548 · Philips Ultrasound, LLC · Sep 2026
EVO X30 Diagnostic Ultrasound System
K263182 · Samsung Medison Co., Ltd. · Sep 2026
Vivid Explorer/Vivid Advanced/Vivid Focus
K261313 · GE Medical Systems Ultrasound and Primary Care Diagnostics · Sep 2026